Transforming Biopharma
Investment Decision-Making

Two investors discuss a pharmaceutical drug, product, or asset

Traditional asset evaluation methods have benefits, but they also have their challenges:

Syndicated Reporting
KOL Input
Primary Research
  • Broad coverage
  • Standardised data
  • Generic insights
  • Lacks customisation
  • Expert knowledge
  • Tailored insights
  • Prone to bias
  • Limited scope
  • Very customisable
  • Up-to-date insights
  • Time-consuming
  • Very high cost

For pharma and biotech investment teams, metAInsights™ is the superior choice.

metAInsights™ offers customized, in-depth analysis using insights from real KOLs, empowering investors to make the right decisions around high-potential opportunities.

Arming You with the
Intelligence You Need

Key AI intelligence is noted down by an investor

Investors need robust knowledge when making decisions around biopharma assets, as a thorough opportunity evaluation is essential in order to minimize risks and maximize returns. A comprehensive approach ensures informed decision-making and positions investments to capitalize on high-value opportunities in a dynamic healthcare market.

Key business questions can include the following:

  • How have the treatment landscape and competitor market share changed?
  • How have similar products performed (adoption, market penetration)?
  • How have market drivers and barriers previously affected similar products?
  • What are the historical market trends and growth rates for the therapeutic area? ​
  • What are the clinical and commercial outcomes for products with similar TPPs?
metAInsights™ answers all these questions - and more - based on validated responses from thousands of verified HCPs and patients.

Powering Your Decisions
with AI and Human Thinking

Two investors compare results from an insightful intelligence report

Created to leverage a vast library of human-generated qualitative biopharma insights, metAInsights™ is designed to help you make smarter investment decisions.

Using state-of-the-art large language models (LLMs), metAInsights™, guided by our expert team, combines 10 years of global pharma asset development studies to bring you the insights you need to make the right investment decisions.

Leverage Unique Insights
Power Decision-Making
Accelerate Vital Research
Access data from 100,000 verified respondents.
Validate your decision-making in just days.
Replace costly interviews with curated reports.
Explore insights from a unique, propriety dataset.
Enhance your sample with more respondents.
Get a steer on your research in just hours.
View a wide range of therapy areas and assets.
Action custom, validated, reliable intelligence.
Reduce hassle by using our trustworthy outputs.

Get in Touch

Four investors discuss an upcoming biopharma/pharmaceutical asset decision

We'd love to hear from you.

If you're interested in finding out more about how metAInsights™ can help you make the right investment decisions, please contact us at business@metainsights.ai.

London

Princeton

Singapore

D2 Dolphin House
Smugglers Way
London
SW18 1DE

5 Schalks Crossing Rd
Suite 210
Plainsboro
NJ 08536

9 Temasek Boulevard
Suntec Tower 2
#29‑01 Singapore
038989, SG

Elements

Text

This is bold and this is strong. This is italic and this is emphasized. This is superscript text and this is subscript text. This is underlined and this is code: for (;;) { ... }. Finally, this is a link.


Heading Level 2

Heading Level 3

Heading Level 4

Heading Level 5
Heading Level 6

Blockquote

Fringilla nisl. Donec accumsan interdum nisi, quis tincidunt felis sagittis eget tempus euismod. Vestibulum ante ipsum primis in faucibus vestibulum. Blandit adipiscing eu felis iaculis volutpat ac adipiscing accumsan faucibus. Vestibulum ante ipsum primis in faucibus lorem ipsum dolor sit amet nullam adipiscing eu felis.

Preformatted

i = 0;
															
															while (!deck.isInOrder()) {
																print 'Iteration ' + i;
																deck.shuffle();
																i++;
															}
															
															print 'It took ' + i + ' iterations to sort the deck.';

Lists

Unordered

  • Dolor pulvinar etiam.
  • Sagittis adipiscing.
  • Felis enim feugiat.

Alternate

  • Dolor pulvinar etiam.
  • Sagittis adipiscing.
  • Felis enim feugiat.

Ordered

  1. Dolor pulvinar etiam.
  2. Etiam vel felis viverra.
  3. Felis enim feugiat.
  4. Dolor pulvinar etiam.
  5. Etiam vel felis lorem.
  6. Felis enim et feugiat.

Icons

Actions

Table

Default

Name Description Price
Item One Ante turpis integer aliquet porttitor. 29.99
Item Two Vis ac commodo adipiscing arcu aliquet. 19.99
Item Three Morbi faucibus arcu accumsan lorem. 29.99
Item Four Vitae integer tempus condimentum. 19.99
Item Five Ante turpis integer aliquet porttitor. 29.99
100.00

Alternate

Name Description Price
Item One Ante turpis integer aliquet porttitor. 29.99
Item Two Vis ac commodo adipiscing arcu aliquet. 19.99
Item Three Morbi faucibus arcu accumsan lorem. 29.99
Item Four Vitae integer tempus condimentum. 19.99
Item Five Ante turpis integer aliquet porttitor. 29.99
100.00

Buttons

  • Disabled
  • Disabled

Form